Vezzoni P, Cairo G, Pozzi M R, Bardella L, Schiaffonati L, Giardini R, Rilke F, Delia D, Biunno I
Diagn Immunol. 1986;4(5):247-52.
The relationship between T cell receptor (TCR) beta and gene immunoglobulin heavy chain locus was investigated in 25 cases of unselected human lymphomas as well as in normal and non-neoplastic lymphoid tissues. Hybridizing our blots with Jurkat 2, a clone specific for the beta chain gene of TCR, did not demonstrate extra bands in non-neoplastic tissues composed of 50-95% T-cells. On the contrary, rearranged bands were detected in six out of six cases of T-cell lymphomas. No TCR beta gene rearrangements were detected in 11 B-cell lymphomas, which in turn presented modification of the immunoglobulin heavy chain gene germline configuration. Our results suggest that TCR beta chain gene rearrangements are a good marker for human T-cell neoplasias in humans and complement the analysis with immunoglobulin genes probes. Eighth samples were devoid of any rearrangements: this group comprises cases of Hodgkin's disease T-lymphoblastic lymphomas in clinical remission and malignancies of unknown origin, as discussed in the text. We conclude that the analysis using DNA probes specific for TCR beta and IgH genes can be of aid to the pathologist in the diagnosis and classification of human lymphomas.
在25例未经选择的人类淋巴瘤以及正常和非肿瘤性淋巴组织中,研究了T细胞受体(TCR)β与基因免疫球蛋白重链基因座之间的关系。用Jurkat 2(一种对TCRβ链基因具有特异性的克隆)对我们的印迹进行杂交,在由50 - 95% T细胞组成的非肿瘤组织中未显示额外条带。相反,在6例T细胞淋巴瘤中的6例中检测到重排条带。在11例B细胞淋巴瘤中未检测到TCRβ基因重排,而这些B细胞淋巴瘤反过来呈现出免疫球蛋白重链基因种系构型的改变。我们的结果表明,TCRβ链基因重排是人类T细胞肿瘤的一个良好标志物,并且可补充免疫球蛋白基因探针的分析。8个样本没有任何重排:如文中所讨论的,该组包括处于临床缓解期的霍奇金病、T淋巴母细胞淋巴瘤以及来源不明的恶性肿瘤病例。我们得出结论,使用针对TCRβ和IgH基因的DNA探针进行分析有助于病理学家对人类淋巴瘤进行诊断和分类。